Targeted Next-Generation Sequencing Analysis Predicts the Recurrence in Resected Lung Adenocarcinoma Harboring <i>EGFR</i> Mutations

Targeted Next-Generation Sequencing Analysis Predicts the Recurrence in Resected Lung Adenocarcinoma Harboring <i>EGFR</i> Mutations

Targeted NGS, widely applied to identify driver oncogenes in advanced lung adenocarcinoma, may also be applied to resected early stage cancers. We investigated resected <i>EGFR</i>-mutated lung adenocarcinoma mutation profiles to evaluate prognostic impacts. Tissues from 131 patients who...

Full description

Bibliographic Details
Main Authors:	In Ae Kim, Jae Young Hur, Hee Joung Kim, Song Am Lee, Jae Joon Hwang, Wan Seop Kim, Kye Young Lee
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Cancers
Subjects:	targeted next-generation sequencing resected <i>EGFR</i> mutated-lung adenocarcinoma <i>CTNNB1</i> post-operative recurrence recurrence-free survival
Online Access:	https://www.mdpi.com/2072-6694/13/14/3632

Similar Items

First-Line EGFR-TKIs Treatment in Stage I Non-Small-Cell Lung Cancer Patients Harboring EGFR Gene Mutations with Postoperative Intrapulmonary Recurrence
by: Zhu Z, et al.
Published: (2021-02-01)

Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: Are They Different from Those with Common <i>EGFR</i> Mutations?
by: Hyun Ae Jung, et al.
Published: (2020-10-01)

A Highly Sensitive Next-Generation Sequencing-Based Genotyping Platform for <i>EGFR</i> Mutations in Plasma from Non-Small Cell Lung Cancer Patients
by: Jung-Young Shin, et al.
Published: (2020-11-01)

Identification and Functional Analysis of a Novel <i>CTNNB1</i> Mutation in Pediatric Medulloblastoma
by: Lide Alaña, et al.
Published: (2022-01-01)

Association Study between Mucin 4 (<i>MUC4</i>) Polymorphisms and Idiopathic Recurrent Pregnancy Loss in a Korean Population
by: Ji-Hyang Kim, et al.
Published: (2022-05-01)

<i>EGFR</i>-Mutant Non-Small-Cell Lung Cancer at Surgical Stages: What Is the Place for Tyrosine Kinase Inhibitors?
by: Xavier Cansouline, et al.
Published: (2022-04-01)

Genetic Association between Inflammatory-Related Polymorphism in <i>STAT3</i>, <i>IL-1β</i>, <i>IL-6</i>, <i>TNF-α</i> and Idiopathic Recurrent Implantation Failure
by: Min Jung Kwon, et al.
Published: (2023-08-01)

Evaluation of the Analytical Performance of Oncomine Lung cfDNA Assay for Detection of Plasma <i>EGFR</i> Mutations
by: Yong Gon Cho, et al.
Published: (2023-06-01)

Molecular Divergence upon <i>EGFR</i>-TKI Resistance Could Be Dependent on the Exon Location of the Original <i>EGFR</i>-Sensitizing Mutation
by: Roberto Serna-Blasco, et al.
Published: (2022-09-01)

Targeted Assessment of the <i>EGFR</i> Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)
by: Sandra Lassalle, et al.
Published: (2020-04-01)

Future Perspectives in Detecting <i>EGFR</i> and <i>ALK</i> Gene Alterations in Liquid Biopsies of Patients with NSCLC
by: Daniela Ferreira, et al.
Published: (2021-04-01)

Concordance of Abundance for Mutational <i>EGFR</i> and Co-Mutational <i>TP53</i> with Efficacy of <i>EGFR</i>-TKI Treatment in Metastatic Patients with Non-Small-Cell Lung Cancer
by: Youping Wang, et al.
Published: (2023-09-01)

Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study
by: In Ae Kim, et al.
Published: (2018-07-01)

Extracellular Vesicle-Based Bronchoalveolar Lavage Fluid Liquid Biopsy for EGFR Mutation Testing in Advanced Non-Squamous NSCLC
by: In Ae Kim, et al.
Published: (2022-05-01)

<i>Gardnerella vaginalis</i> in Recurrent Urinary Tract Infection Is Associated with Dysbiosis of the Bladder Microbiome
by: Jeong-Ju Yoo, et al.
Published: (2022-04-01)

Association of Polymorphisms in the Long Non-Coding RNA <i>HOTAIR</i> with Recurrent Pregnancy Loss in a Korean Population
by: Hyeon Woo Park, et al.
Published: (2022-11-01)

Treatment Strategies for Non-Small Cell Lung Cancer Harboring Common and Uncommon EGFR Mutations: Drug Sensitivity Based on Exon Classification, and Structure-Function Analysis
by: Rui Kitadai, et al.
Published: (2022-05-01)

Non-Small Cell Lung Cancer Harboring Concurrent <i>EGFR</i> Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma
by: Valerio Gristina, et al.
Published: (2021-06-01)

Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo <i>MET</i> Amplification in Patients with Metastatic <i>EGFR</i>-Mutated NSCLC
by: Edyta M. Urbanska, et al.
Published: (2023-08-01)

The Root Extract of <i>Peucedanum praeruptorum</i> Dunn Exerts Anticancer Effects in Human Non-Small-Cell Lung Cancer Cells with Different <i>EGFR</i> Mutation Statuses by Suppressing MET Activity
by: Hyun-Ji Park, et al.
Published: (2022-04-01)

Dynamic Evaluation of Circulating miRNA Profile in <i>EGFR</i>-Mutated NSCLC Patients Treated with EGFR-TKIs
by: Alessandro Leonetti, et al.
Published: (2021-06-01)

Efficacy of befotertinib in non-small cell lung cancer harboring uncommon compound EGFR mutations G719X and S768I: a case report
by: Zhedong Zhang, et al.
Published: (2024-04-01)

The p53-Driven Anticancer Effect of <i>Ribes fasciculatum</i> Extract on AGS Gastric Cancer Cells
by: Myeong-Jin Kim, et al.
Published: (2022-02-01)

Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less <i>KRAS</i> and More <i>EGFR</i> Mutations Compared to Advanced Adenocarcinomas
by: Jennie Petterson, et al.
Published: (2024-03-01)

Liquid Biopsy in <i>EGFR</i>-Mutated Advanced NSCLC from T790M to <i>MET</i> Amplification: Clinical Implications and Possibilities in the Resistance Setting
by: Luigi Della Gravara, et al.
Published: (2023-04-01)

Targeting <i>BRAF</i> Activation as Acquired Resistance Mechanism to EGFR Tyrosine Kinase Inhibitors in <i>EGFR</i>-Mutant Non-Small-Cell Lung Cancer
by: Frank Aboubakar Nana, et al.
Published: (2021-09-01)

Lysine Deprivation Induces AKT-AADAT Signaling and Overcomes EGFR-TKIs Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer Cells
by: Chia-Chi Hsu, et al.
Published: (2021-01-01)

Adjuvant EGFR-TKIs for Patients With Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis of 1,283 Patients
by: Rui-Lian Chen, et al.
Published: (2021-04-01)

<i>TP53</i> Co-Mutation Status Association with Clinical Outcomes in Patients with <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer
by: Xiuning Le, et al.
Published: (2022-12-01)

Mutational Profiling of Lung Cancer Using Next Generation Sequencing: A Malaysian Real-World Clinical Diagnostic Experience
by: Pathmanathan Rajadurai, et al.
Published: (2023-01-01)

NSAIDs Overcome <i>PIK3CA</i> Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models
by: Hua Li, et al.
Published: (2022-01-01)

Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations
by: Michihiro Kunishige, et al.
Published: (2023-12-01)

The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis
by: Justina Bekampytė, et al.
Published: (2021-08-01)

Utility of Next-Generation Sequencing in the Reconstruction of Clonal Architecture in a Patient with an <i>EGFR</i> Mutated Advanced Non-Small Cell Lung Cancer: A Case Report
by: Javier Simarro, et al.
Published: (2022-05-01)

Association between <i>EGFR</i> Gene Mutation and Antioxidant Gene Polymorphism of Non-Small-Cell Lung Cancer
by: Ching-Hsiung Lin, et al.
Published: (2020-09-01)

Hope and Challenges: Immunotherapy in <i>EGFR</i>-Mutant NSCLC Patients
by: Dan Yan
Published: (2023-10-01)

The Role of Bezlotoxumab for the Prevention of Recurrent <i>Clostridioides difficile</i> Infections: A Review of the Current Literature and Paradigm Shift after 2021
by: Melanie L. Hyte, et al.
Published: (2022-09-01)

Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing <i>EGFR</i> Mutations
by: Hisao Imai, et al.
Published: (2021-05-01)

Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA
by: Jong Sik Lee, et al.
Published: (2018-12-01)

Exosomes from <i>EGFR</i>-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion
by: Amina Jouida, et al.
Published: (2022-08-01)